

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment o...
Q2 2026
Jul 30, 2026
Q1 2026
May 13, 2026
FY 2025
Mar 24, 2026
Q4 2025
Mar 24, 2026
Q3 2025
Nov 4, 2025